Literature DB >> 33320258

Tobacco Products and the Risks of SARS-CoV-2 Infection and COVID-19.

Jonathan M Samet1.   

Abstract

IMPLICATIONS: This commentary addresses the state of the evidence on tobacco products, nicotine, and COVID-19. The evidence of the effects of smoking on respiratory infections and the immune system in general are examined and the current understanding of tobacco products and risk for SARS-CoV-2 infection and the course of COVID-19 is addressed.
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Research on Nicotine and Tobacco.

Entities:  

Year:  2020        PMID： 33320258     DOI： 10.1093/ntr/ntaa187

Source DB:  PubMed          Journal:  Nicotine Tob Res        ISSN： 1462-2203            Impact factor:   4.244


  2 in total

Review 1.  PERSPECTIVE: Current US COVID-19 Pandemic Substance Use Research and Ideas for Research That May Help Us Learn More.

Authors:  Sarah Q Duffy
Journal:  J Ment Health Policy Econ       Date:  2021-12-01

2.  County-level demographic, social, economic, and lifestyle correlates of COVID-19 infection and death trajectories during the first wave of the pandemic in the United States.

Authors:  Natalie C DuPre; Seyed Karimi; Charlie H Zhang; Lyndsey Blair; Arushi Gupta; Lamyaa Mousa A Alharbi; Mariyam Alluhibi; Riten Mitra; W Paul McKinney; Bert Little
Journal:  Sci Total Environ       Date:  2021-05-03       Impact factor: 7.963
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.